110 related articles for article (PubMed ID: 20597007)
41. Phosphatidylcholine and the intestinal mucus layer: in vitro efficacy against Clostridium difficile-associated polymorphonuclear neutrophil activation.
Olson A; Diebel LN; Liberati DM
Am J Surg; 2015 Mar; 209(3):493-7. PubMed ID: 25595713
[TBL] [Abstract][Full Text] [Related]
42. The prospect for vaccines to prevent Clostridium difficile infection.
Ghose C; Kelly CP
Infect Dis Clin North Am; 2015 Mar; 29(1):145-62. PubMed ID: 25677708
[TBL] [Abstract][Full Text] [Related]
43. Inhibition of adhesion of Clostridium difficile to human intestinal cells after treatment with serum and intestinal fluid isolated from mice immunized with nontoxigenic C. difficile membrane fraction.
Senoh M; Iwaki M; Yamamoto A; Kato H; Fukuda T; Shibayama K
Microb Pathog; 2015 Apr; 81():1-5. PubMed ID: 25745878
[TBL] [Abstract][Full Text] [Related]
44. The P2Y6 receptor mediates Clostridium difficile toxin-induced CXCL8/IL-8 production and intestinal epithelial barrier dysfunction.
Hansen A; Alston L; Tulk SE; Schenck LP; Grassie ME; Alhassan BF; Veermalla AT; Al-Bashir S; Gendron FP; Altier C; MacDonald JA; Beck PL; Hirota SA
PLoS One; 2013; 8(11):e81491. PubMed ID: 24278446
[TBL] [Abstract][Full Text] [Related]
45. Clostridium difficile toxins A and B can alter epithelial permeability and promote bacterial paracellular migration through HT-29 enterocytes.
Feltis BA; Wiesner SM; Kim AS; Erlandsen SL; Lyerly DL; Wilkins TD; Wells CL
Shock; 2000 Dec; 14(6):629-34. PubMed ID: 11131913
[TBL] [Abstract][Full Text] [Related]
46. Secreted Compounds of the Probiotic Bacillus clausii Strain O/C Inhibit the Cytotoxic Effects Induced by Clostridium difficile and Bacillus cereus Toxins.
Ripert G; Racedo SM; Elie AM; Jacquot C; Bressollier P; Urdaci MC
Antimicrob Agents Chemother; 2016 Jun; 60(6):3445-54. PubMed ID: 27001810
[TBL] [Abstract][Full Text] [Related]
47. Human colonic aspirates containing immunoglobulin A antibody to Clostridium difficile toxin A inhibit toxin A-receptor binding.
Kelly CP; Pothoulakis C; Orellana J; LaMont JT
Gastroenterology; 1992 Jan; 102(1):35-40. PubMed ID: 1309359
[TBL] [Abstract][Full Text] [Related]
48. Immunogenicity and protective efficacy of Clostridium difficile spore proteins.
Ghose C; Eugenis I; Edwards AN; Sun X; McBride SM; Ho DD
Anaerobe; 2016 Feb; 37():85-95. PubMed ID: 26688279
[TBL] [Abstract][Full Text] [Related]
49. Anti-Clostridium difficile bovine immunoglobulin concentrate inhibits cytotoxicity and enterotoxicity of C. difficile toxins.
Kelly CP; Pothoulakis C; Vavva F; Castagliuolo I; Bostwick EF; O'Keane JC; Keates S; LaMont JT
Antimicrob Agents Chemother; 1996 Feb; 40(2):373-9. PubMed ID: 8834883
[TBL] [Abstract][Full Text] [Related]
50. Intestinal Epithelial Cell Response to Clostridium difficile Flagella.
Batah J; Kansau I
Methods Mol Biol; 2016; 1476():103-16. PubMed ID: 27507336
[TBL] [Abstract][Full Text] [Related]
51. Reinforcement of the intestinal mucus layer protects against Clostridium difficile intestinal injury in vitro.
Diebel LN; Liberati DM
J Am Coll Surg; 2014 Sep; 219(3):460-8. PubMed ID: 25067805
[TBL] [Abstract][Full Text] [Related]
52. Effect of Clostridium difficile toxin A on human colonic lamina propria cells: early loss of macrophages followed by T-cell apoptosis.
Mahida YR; Galvin A; Makh S; Hyde S; Sanfilippo L; Borriello SP; Sewell HF
Infect Immun; 1998 Nov; 66(11):5462-9. PubMed ID: 9784558
[TBL] [Abstract][Full Text] [Related]
53. Essential role of toxin A in C. difficile 027 and reference strain supernatant-mediated disruption of Caco-2 intestinal epithelial barrier function.
Sutton PA; Li S; Webb J; Solomon K; Brazier J; Mahida YR
Clin Exp Immunol; 2008 Sep; 153(3):439-47. PubMed ID: 18505424
[TBL] [Abstract][Full Text] [Related]
54. CbpA: a novel surface exposed adhesin of Clostridium difficile targeting human collagen.
Tulli L; Marchi S; Petracca R; Shaw HA; Fairweather NF; Scarselli M; Soriani M; Leuzzi R
Cell Microbiol; 2013 Oct; 15(10):1674-87. PubMed ID: 23517059
[TBL] [Abstract][Full Text] [Related]
55. Enterotoxin A of Clostridium difficile and alpha-Gal epitopes.
Pothoulakis C
Subcell Biochem; 1999; 32():215-27. PubMed ID: 10391997
[No Abstract] [Full Text] [Related]
56. Role of retinol in protecting epithelial cell damage induced by Clostridium difficile toxin A.
Maciel AA; Oriá RB; Braga-Neto MB; Braga AB; Carvalho EB; Lucena HB; Brito GA; Guerrant RL; Lima AA
Toxicon; 2007 Dec; 50(8):1027-40. PubMed ID: 17825865
[TBL] [Abstract][Full Text] [Related]
57. A real-time quantitative PCR assay for evaluating Clostridium difficile adherence to differentiated intestinal Caco-2 cells.
Dingle T; Mulvey GL; Humphries RM; Armstrong GD
J Med Microbiol; 2010 Aug; 59(Pt 8):920-924. PubMed ID: 20413620
[TBL] [Abstract][Full Text] [Related]
58. Inhibition of the cytotoxic effect of Clostridium difficile in vitro by Clostridium butyricum MIYAIRI 588 strain.
Woo TDH; Oka K; Takahashi M; Hojo F; Osaki T; Hanawa T; Kurata S; Yonezawa H; Kamiya S
J Med Microbiol; 2011 Nov; 60(Pt 11):1617-1625. PubMed ID: 21700738
[TBL] [Abstract][Full Text] [Related]
59. [Advances in Clostridioes difficile genome editing].
Hong W; Wan W; Cui G; Guan Z; Qi X; Yu W
Sheng Wu Gong Cheng Xue Bao; 2020 Feb; 36(2):210-225. PubMed ID: 32147994
[TBL] [Abstract][Full Text] [Related]
60.
Dong L; Tomassen MM; Ariëns RMC; Oosterink E; Wichers HJ; Veldkamp T; Mes JJ; Govers C
Food Funct; 2021 Oct; 12(19):9248-9260. PubMed ID: 34606540
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
